First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy
Clinical trial NCT06667167 · RECRUITING
Trial details
- NCT number
- NCT06667167
- Sponsor
- Nir Peled
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-24
- Primary completion
- 2027-11-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.